作者：
Hélène,Asnagli [1]
;
Norbert,Minet [2]
;
Christina,Pfeiffer [3]
;
Eef,Hoeben [4]
;
Rebecca,Lane [1]
;
David,Laughton [5]
;
Louise,Birch [5]
;
Geraint,Jones [5]
;
Andrew,Novak [5]
;
Andrew E,Parker [5]
;
Heinz,Ludwig [1]
;
Alain,Fischer [4]
;
Sylvain,Latour [6]
;
Philip A,Beer [7]
作者单位：
Step Pharma, Saint-Genis-Pouilly, France.
[1]
Laboratory of Lymphocyte Activation and Susceptibility to EBV infection, INSERM UMR 1163, Imagine Institute, Paris, France.
[2]
Université de Paris, France.
[3]
Department of Medicine I, Klinik Ottakring, Wilhelminen Cancer Research Institute, Vienna, Austria.
[4]
Sygnature Discovery, Nottingham, United Kingdom.
[5]
INSERM UMR 1163, Imagine Institute, Paris, France.
[6]
Collège de France, Paris, France.
[7]
DOI
10.1097/HS9.0000000000000864
PMID
37008165
发布时间
2023-04-12
换一批
换一批
